SEBIVO(R) (Telbivudine) Approved In China As New Treatment Option For Patients With Chronic Hepatitis B

Sat, 03 Mar 2007 02:00 PM EST

... Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX) announced today that SEBIVO(R) (telbivudine) has received approval from the Chinese State Food and Drug Administration (SFDA) as a once-a-day treatment, taken orally with or without food, for the treatment of chronic hepatitis B (CHB). [click link for full article] ...